D. McKINSTRY

发表

A New Class of Diuretic-Saluretic Agents, The α, β-Unsaturated Ketone Derivatives of Aryloxyacetic Acids

K. Beyer, J. E. Baer, J. K. Michaelson, 1964 .

Antihypertensive effect of the oral angiotensin converting-enzyme inhibitor SQ 14225 in man.

H. Gavras, R. Vukovich, I. Gavras, 1978, The New England journal of medicine.

Effect of Food on the Bioavailability of Captopril in Healthy Subjects

J. M. Shaw, S. Singhvi, D. Willard, 1982, Journal of clinical pharmacology.

Determination of total captopril in human plasma by gas chromatography-mass spectrometry with selected-ion monitoring after reduction of disulfides.

E. Ivashkiv, A. Cohen, D. McKINSTRY, 1984, Journal of pharmaceutical sciences.

Multiple-dose pharmacokinetics of the monobactam azthreonam (SQ 26,776) in healthy subjects

E. Swabb, A. Sugerman, D. McKINSTRY, 1983, Antimicrobial Agents and Chemotherapy.

Pharmacokinetics of Captopril in Healthy Subjects and in Patients with Cardiovascular Diseases

B. H. Migdalof, K.L. Duchin, D.N. McKinstry, 1988, Clinical pharmacokinetics.

Renal handling of captopril: Effect of probenecid

S. Singhvi, D. Willard, B. H. Migdalof, 1982, Clinical pharmacology and therapeutics.

Interruption of the Renin‐Angiotensin System in Hypertensive Patients by Captopril Induces Sustained Reduction in Aldosterone Secretion, Potassium Retention and Natriuresis

J. Laragh, D. Mckinstry, D. Case, 1979, Hypertension.

Clinical experience with blockade of the renin-angiotensin-aldosterone system by an oral converting-enzyme inhibitor (SQ 14,225, captopril) in hypertensive patients.

J. Laragh, D. Case, J. Sealey, 1978, Progress in cardiovascular diseases.

Acetylcholine release from the cat superior cervical ganglion by carbachol.

G. Koelle, D. McKINSTRY, D. McKinstry, 1967, The Journal of pharmacology and experimental therapeutics.

THE RELEASE OF ACETYLCHOLINE FROM A SYMPATHETIC GANGLION BY CARBACHOL. RELATIONSHIP TO THE FUNCTIONAL SIGNIFICANCE OF THE LOCALIZATION OF ACETYLCHOLINESTERASE.

G. Koelle, W. Koelle, E. Koenig, 1963, Canadian journal of biochemistry and physiology.

Inhibition of Release of Acetylcholine by Strychnine and its Implications regarding Transmission by the Olivo-cochlear Bundle

G. Koelle, D. McKINSTRY, D. McKinstry, 1967, Nature.

A SPECIFIC ORALLY ACTIVE INHIBITOR OF ANGIOTENSIN-CONVERTING ENZYME IN MAN

H. Gavras, H. Brunner, G. Turini, 1977, The Lancet.

Protecting the poor metaboliser‐from what? [letter]

D. Willard, D. Mckinstry, K. Duchin, 1984 .

Oral angiotensin-converting enzyme inhibitor in long-term treatment of hypertensive patients.

H. Gavras, R. Vukovich, B. Waeber, 1979, Annals of internal medicine.

Hemodynamic and Antihypertensive Effects of Captopril, an Orally Active Angiotensin Converting Enzyme Inhibitor

D. Mckinstry, J. Sullivan, E. Muirhead, 1979, Hypertension.